Compare Across Protocol (ACX) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Across Protocol vs Injective — how do they compare? Across Protocol trades at Rp734.4 (market cap Rp505,3M, Rp188,8M 24h volume), while Injective trades at Rp76,160 (market cap Rp7,84T, Rp671,51M 24h volume). The key difference: Injective is far larger — about 15515.5× Across Protocol 's market cap, and Across Protocol 's supply is capped (716,5M / 1B ACX (72%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Injective for 37 Days on average.
| ACX | INJ | |
|---|---|---|
Market Cap | Rp505,3M | Rp7,84T |
Volume (24h) | Rp188,8M | Rp671,51M |
Circulating Supply | 716,5M / 1B ACX (72%) | 100M INJ |
Typical Hold Time | 57 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Across Protocol
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
